DIČ-Searching.cz

DIČ-Searching v


Všechny informace o:

                        
Jméno

CNX Therapeutics Limited

Adresa
Labs House
15-19 Bloomsbury Way
London
London
WC1A 2TH
VAT ID (DIČ)
Stav DIČ Aktivní Neaktivní National Registration Only
VAT Registration Date
5. únor 2024
Company Register Address 3 Bunhill Row
London
EC1Y 8YZ
Company No. 03363032 Show on Companies House
Accountssmall
last accounts made up to 31. březen 2022
Sector (SIC)46460 Wholesale of pharmaceutical goods
Company Register Statusactive
Previous Names
  • Sunovion Pharmaceuticals Europe LTD
  • Dainippon Sumitomo Pharma Europe LTD.
  • Sumitomo Pharmaceuticals Europe Limited
  • KYC Check
    KYC / PEP / AML request
    This data is incorrect?
    Sources: VAT information: HMRC (gov.uk/check-uk-vat-number), Company Register: Companies House (companieshouse.gov.uk)

    Quick access

    Persons with Significant Control (2)

    Source: Companies House
    gb-flag GB Solar Bidco Limited Status: Active Notified: 17/08/2021 Companies House Number: 13512924 Nature of Control
  • Ownership of shares - 75% or more
  • Ownership of voting rights - 75% or more
  • Right to appoint and remove directors
  • gb-flag GB Sumitomo Dainippon Pharma Co., Ltd. Status: Ceased Notified: 06/04/2016 Ceased: 17/08/2021 Companies House Number: 00001200 Nature of Control
  • Ownership of shares - 75% or more
  • Ownership of voting rights - 75% or more
  • Officers (2)

    Source: Companies House
    Clark, Guy Hedley London, England Status: Active Notified: 12/01/2022 Date of Birth: 09/1969 Occupation: Chief Executive Officer Role: Director Country of Residence: England Nationality: British
    Lund, Olga Feodorovna London, England Status: Active Notified: 17/08/2021 Date of Birth: 08/1972 Occupation: Finance Director Role: Director Country of Residence: France Nationality: British

    Companies Controlled by This Company (1)

    gb-flag GB Solar UK Opco Limited Status: Active Notified: 27/07/2022 Companies House Number: 14223376 Nature of Control
  • Ownership of shares - 75% or more
  • Ownership of voting rights - 75% or more
  • Right to appoint and remove directors